Fri, Nov 21, 2014, 7:45 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Amylin Pharmaceuticals, Inc. Message Board

  • kevinmik kevinmik Jun 9, 2011 12:18 PM Flag

    Lilly's own Once Weekly GLP-1 Drug Candidate

    It seems to me Lilly's existing late stage development program for a Once A Week GLP-1 Drug is the biggest threat and question mark surrounding the Amylin/Lilly Partnership. The fact the drug is only in the development stage, kind of keeps Amylin from making it a legal issue at this time. However there will come a day when Lilly moves the drug from development into regulatory approval and that's when I believe Amylin can start taking legal action. Besides having recourse in a court of law, there is also the court of public opinion and for that, I would love to see Amylin put all the issues they have with Liily including Lilly's Once a Week GLP-1 Drug Candidate on the table today and publicly confront their partner Lilly. Amylin must insist that Lilly needs to explain to everyone how they plan to fairly promote two separate Once Weekly GLP-1 drugs in the same marketplace and not have it become a breachable offense against the Amylin/Lilly Collaboration Agreement. Amylin needs to put all the issues they have with Lilly on the table and make them public today, so everyone can see where the two company's are coming from.


    SortNewest  |  Oldest  |  Most Replied Expand all replies

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Foot Locker, Inc.
NYSEFri, Nov 21, 2014 4:00 PM EST
Aruba Networks, Inc.
NasdaqGSFri, Nov 21, 2014 4:00 PM EST
Ross Stores Inc.
NasdaqGSFri, Nov 21, 2014 4:00 PM EST